Who will get levomilnacipran and cariprazine?

Quote






Hopefully you have heard, ethicare is losing Savella. Most likely we will be like the todorza side and have a "depression line call" followed by lz and bys. Pure guess but based on huge market potential of the schiz/bipolar drug, we will eventually lose Bystolic too. The bipolar drug has the most blockbuster potential of any of our new drugs so that will definitely replace some inline brands and be promoted by multiple reps.
 






I don't have any info, but based on what was just said it seems like FTI would get the Savella Jr drug since FTI is weighted most on VB now. FEC gets all the breaks on new drugs and better weightings, etc
 












Anonymous said:
Probably hospital since neither.of these 2 drugs are acute care. Selling hospitals products that do not need to be started in hospital makes perfect sense.
Click to expand...

Lol, you made me burst out laughing! I was going to reply with similar sentiments since I'm extremely frustrated with the products they keep dumping on us. When I interviewed for the hospital spot a few years ago, my manager told me that we'd only be selling acute care products. Ha! What a joke!
 






Anonymous said:
Hopefully you have heard, ethicare is losing Savella. Most likely we will be like the todorza side and have a "depression line call" followed by lz and bys. Pure guess but based on huge market potential of the schiz/bipolar drug, we will eventually lose Bystolic too. The bipolar drug has the most blockbuster potential of any of our new drugs so that will definitely replace some inline brands and be promoted by multiple reps.
Click to expand...

Takeda bipolar drug is going to kick your ass just like Amitiza is kicking Linzess' ass.
 
























Top Bottom
Back
Quote